In an article for the New York Times, Donald McNeil reported, “With insulin prices skyrocketing and substantial shortages developing in poorer countries, the World Health
New diabetes treatments can be hard to keep track of. Here we take a look at some of the newer treatments and trials for diabetes.
Novo Nordisk UK has announced that Ozempic (semaglutide), a new once-weekly GLP-1 analogue injection for the treatment of Type 2 diabetes is now available in
Commenting on news stories about the possibility of medical supplies being jeopardized by the looming decision about Britain leaving the EU, JDRF has affirmed that
An 80-year-old man with T2 diabetes has improved his health by attending Walking Cricket sessions, proving it’s never too late to start exercising after taking